載入...
A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial
STUDY OBJECTIVE: A safe alternative to erythropoiesis‐stimulating agents to treat anemia is warranted in patients with cancer and anemia; thus the objective of this trial was to compare the efficacy and safety of intravenous (IV) iron isomaltoside with oral iron in patients with cancer and anemia by...
Na minha lista:
發表在: | Pharmacotherapy |
---|---|
Main Authors: | , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
John Wiley and Sons Inc.
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071650/ https://ncbi.nlm.nih.gov/pubmed/26927900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1729 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|